Congratulations to Dr. Ed Reznik on his 2019 Young Investigator Award from the Kidney Cancer Association on Metabolic determinants of the tumor microenvironment and sensitivity to immunotherapy in ccRCC. The introduction of immunotherapy has transformed the management of advanced kidney cancer. Although many kidney cancer patients benefit from immunotherapy, there is a formidable gap in...Read More
Text Widget
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada magna mollis euismod.
Recent Comments